Find an Eye MD near you!

Embattled drugmaker Valeant Pharmaceuticals has struck a deal with Walgreens to distribute some of its drugs at a 10% discount.

Mundipharma and Purdue Pharma Canada have acquired marketing rights to Merck’s glaucoma portfolio outside of the United States.

Cellceutix Corporation announced that the U.S. FDA granted rare pediatric disease designation to kevetrin for the treatment of retinoblastoma.

Communicating with patients using cap color exclusively could lead to confusion and harm, especially when treating patients with more advanced disease.

A retrospective study found that a commonly prescribed drug for Parkinson’s, L-DOPA, may delay or prevent AMD.

This study adds to the growing body of literature that suggests natamycin may be more effective for treating fungal keratitis than voriconazole.